Olmesartan Medoxomil Nanomicelle Using Soluplus for Dissolution Enhancement :Preparation, In-vitro and Ex-vivo Evaluation
The antihypertensive medication olmesartan medoxomil (OLM) is pharmacologically selective angiotensin-II receptor antagonist. Pharmaceutically speaking, OLM is a class II medication (low solubility, high permeability) that is practically insoluble.Due to its extremely poor solubility, which negati...
Saved in:
| Main Authors: | Nawal Ayash Rajab, Halah Talal Sulaiman |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
College of Pharmacy University of Baghdad
2025-06-01
|
| Series: | Iraqi Journal of Pharmaceutical Sciences |
| Subjects: | |
| Online Access: | https://bijps.uobaghdad.edu.iq/index.php/bijps/article/view/3015 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Brimonidine-Soluplus Nanomicelles: Preparation and in-vitro evaluation
by: Noor Al wiswasi, et al.
Published: (2025-03-01) -
Preparation and Characterization of Olmesartan Medoxomil-Loaded Polymeric Mixed Micelle Nanocarrier
by: Halah Talal Sulaiman, et al.
Published: (2025-02-01) -
Self-assembled latanoprost loaded soluplus nanomicelles as an ophthalmic drug delivery system for the management of glaucoma
by: Shazma Gohar, et al.
Published: (2024-11-01) -
Preparation of novel luminescent nanomicelles responsive to neutrophils and their imaging application in mouse burn model
by: HU Tao, et al.
Published: (2025-02-01) -
Pharmacokinetic and Pharmacodynamic Study of Folic Acid-Modified Chitosan–Stearic Acid Nanomicelles Loaded with Tetrandrine for Rheumatoid Arthritis
by: Shuai Ma, et al.
Published: (2025-01-01)